Viridian Therapeutics

Youtube Subscribe

Open: 22.1 Close: 20.43 Change: -1.67

8 things an AI found about Viridian Therapeutics Company Inc that you should know before investing.

The game is changing. There is a new strategy to evaluate Viridian Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Viridian Therapeutics are: Viridian, Therapeutics, candidate, thyroid, eye, disease, company, …

Concept Map

Semantic Network

Stock Summary

Viridian Therapeutics shares rise 8.7% after selecting go-forward candidate for thyroid eye disease treatment. Company had revenue of $347.00K in the twelve months ending September 30, 2023. Viridian had a.

Today's Summary

Viridian Therapeutics shares rise 8.7% after selecting go-forward candidate for thyroid eye disease treatment. Company had revenue of $347.00K in the twelve months ending September 30, 2023. Viridian had a negative net margin of 62,437.76% and a negative return on equity of 108.58%.

Today's News

Viridian Therapeutics shares rise 8.7% after selecting go-forward candidate for thyroid eye disease treatment. Company had revenue of $347.00K in the twelve months ending September 30, 2023. Viridian Therapeutics has a 1-year low of $10.93 and a 1 year high of $39.00. The company last issued its earnings results on Monday, November 13th. Viridian Therapeutics ( NASDAQ:VRDN – Get Free Report ) last announced its earnings results on Monday, November 13th. Viridian had a negative net margin of 62,437.76% and a negative return on equity of 108.58%. Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Today, the firm is suggested as a BUY with a 0.41-star rating and a target price of $30.00.

Stock Profile

" Viridian Therapeutics shares rise 8.7% after selecting go-forward candidate for thyroid eye disease treatment. Company had revenue of $347.00K in the twelve months ending September 30, 2023. Viridian Therapeutics has a 1-year low of $10.93 and a 1 year high of $39.00. The company last issued its earnings results on Monday, November 13th. Viridian Therapeutics ( NASDAQ:VRDN – Get Free Report ) last announced its earnings results on Monday, November 13th. Viridian had a negative net margin of 62,437.76% and a negative return on equity of 108.58%. Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Today, the firm is suggested as a BUY with a 0.41-star rating and a target price of $30.00."

Keywords

How much time have you spent trying to decide whether investing in Viridian Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Viridian Therapeutics are: Viridian, Therapeutics, candidate, thyroid, eye, disease, company, and the most common words in the summary are: therapeutic, viridian, stock, clinical, company, news, trial, . One of the sentences in the summary was: Viridian Therapeutics shares rise 8.7% after selecting go-forward candidate for thyroid eye disease treatment. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #viridian #stock #clinical #company #news #trial.

Read more →

Youtube Subscribe

---